| Home | E-Submission | Sitemap | Contact Us |  
logo
The Korean Journal of Medicine 2009;77(5): 565-570.
Extranodal NK/T-cell lymphoma (ENKL)의 최신지견
김원석
Recent updates on extranodal NK/T-cell lymphoma
Won Seog Kim
ABSTRACT
Extranodal NK/T-cell lymphoma (ENKL) is a rare subtype of NHL (Non-Hodgkin lymphoma]. It occurs mostly in the nasal and paranal areas. Most of the cases are presented stage I/II. International prognostic index (IPI) can predict the outcome. However, better prognostic model is available such as NKIPI. Because of high expression of p-glycoprotein, ENKL is refractory to chemotherapy. Early stage disease can be bestly treated with concurrent chemoradiation. For advanced stage disease, new clinical trials are now being conducted.
Keywords: Extranodal NK/T-cell lymphoma
TOOLS
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
  E-Mail
Share:      
METRICS
594
View
14
Download
Recent Update on RANKL Inhibitor  2018 June;93(3)
Recent Advances of Peroral Cholangioscopy  2018 April;93(2)
Recent Advances of Antiretroviral Agents  2016 June;90(6)
Recent Update in Diabetic Nephropathy  2015 September;89(3)
Recent Updates on Chemotherapy-Induced Peripheral Neuropathy  2015 January;88(1)
Editorial Office
101-2501, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-2271-6791   Fax: +82-2-790-0993    E-mail: kaim@kams.or.kr
About |  Browse Articles |  Current Issue |  For Authors and Reviewers
Copyright © The Korean Association of Internal Medicine. All rights reserved.                powerd by m2community